pediatric HIV

Impact of male partner involvement on mother-to-child transmission of HIV and HIV-free survival among HIV-exposed infants in rural South Africa: Results from a two phase randomised controlled trial

The Sub-Saharan Africa region still remains the epicentre of the global HIV/AIDS epidemic. With regards to new paediatric HIV infections, almost 90% of new HIV infections are among children (aged 0-14 years), largely through mother to child transmission. Male Partner Involvement in Prevention of Mother to Child Transmission programmes is now strongly advocated as being key in improving infant outcomes. This study describes the role of Male Partner Involvement on infant HIV infection and mortality survival in the first year among HIV-exposed infants born from HIV positive mothers.
Include in home page features rotation
Off

12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study

Author
Karl-Günter Technau, Renate Strehlau, Faeezah Patel, Stephanie Shiau, Megan Burke, Martie Conradie, Gillian Sorour, Gayle G Sherman, Ashraf Coovadia, Pamela M Murnane, Elaine J Abrams, Louise Kuhn
Initiation of antiretroviral therapy (ART) following diagnosis of HIV infection at birth is an emerging area of paediatric HIV care. We present outcomes of HIV-infected infants identified at birth at Rahima Moosa Mother and Child Hospital in Johannesburg, South Africa.
Include in home page features rotation
Off

4th Southern African HIV Clinicians Society Conference

The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics, from new antiretroviral drugs, AIDS-related complications, and opportunistic infections, to promoting adherence and ethical issues.

Include in home page features rotation
Off

Leaving no child behind: best practices and lessons learned from the ACT initiative

Bright and early Wednesday morning, nine speakers and more than 70 participants from international development organizations, donor agencies, and academia gathered at AIDS 2018 to discuss best practices and lessons learned from The Accelerating Children’s HIV/AIDS Treatment (ACT), reflecting how we can sustain and continue to accelerate progress in reaching children and adolescents living with HIV. Participants asked thoughtful questions and engaged in lively discussion with the panel of speakers, including reflection on challenges with case identification and the need for countries to strategically position point of care diagnostics.
Author
Johanna Theunissen, Communications Officer, Baylor College of Medicine Children’s Foundation/SHARE staff

JAIDS supplement: Post-program learning and knowledge from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative

Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Articles include:

Include in home page features rotation
Off

Enhancing HIV Retention and Clinical Outcomes in Tanzania through Pediatric- and Adolescent-Friendly Services

Author
Redempta Mbatia, Samwel Kikaro, Edward Mgelea, Francis Nyabukene, Christopher Henjewele, Lydia Temba, Sisty Moshi, Agnes Rubare, and Benedicta Masanja

Despite global reductions in AIDS-related deaths among adults, the rate for children increased by 50 percent. This increase points to inadequate testing, counselling, and treatment coverage and poor retention in services for these children. Pediatric- and adolescent-friendly health services have the potential to improve retention and clinical outcomes among children living with HIV. This study was conducted to provide evidence of the effectiveness of pediatric- and adolescent-friendly clinics in Kigoma, Tanzania.

Include in home page features rotation
Off

Lopinavir/ritonavir (LPV/r) Pellet Toolkit

Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section. The toolkit also provides clinical information on LPV/r pellets in the Health Care Worker section, including recommendations on dosing and administration of the medication, as well as resources for working with caregivers.

Call for Abstracts: 4th Southern African HIV Clinicians Society Conference

Closing date

The Southern African HIV Clinicians Society’s biannual conference focuses on clinical content for HIV and TB health care workers. The 2018 conference programme has been carefully designed to benefit all health care practitioners, with topics ranging from new antiretroviral drugs, AIDS-related complications, opportunistic infections, promoting adherence and ethical issues.

Clinic-Community Collaboration (C3) Toolkit

Is the resource available on the Internet?
Yes
Author
PATA & PACF

The Pediatric-Adolescent Treatment Africa (PATA) and the Positive Action for Children Fund (PACF) have worked across 9 countries and facilitated 36 clinic-community collaborations through their partnership on the three-year Clinic-CBO Collaboration (C3) Programme, which aims to strengthen partnerships between clinics and community-based organisations (CBOs) to improve paediatric case finding and HIV treatment.

Include in home page features rotation
Off
Subscribe to pediatric HIV